Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model

Nuclear Medicine and Biology

Volumn 33, Issue 8, 2006, Pages 963-969

  Yoshimoto, Mitsuyoshi ^a   Kinuya, Seigo ^a   Kawashima, Atsuhiro ^b   Nishii, Ryuichi ^c,d   Yokoyama, Kunihiko ^a   Kawai, Keiichi ^a,d  

^a KANAZAWA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KANAZAWA MEDICAL CENTER   (Japan)

^c Fujimoto Hayasuzu Hospital   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

Author keywords

Angiogenesis; Tumor imaging; VEGF; VEGF receptors

Indexed keywords

IODINE 125; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; RADIOIODINATION; TUMOR GROWTH; TUMOR VOLUME; UTERUS; XENOGRAFT;

ANGIOSTATINS; ANIMALS; AUTORADIOGRAPHY; CELL LINE, TUMOR; ENDOSTATINS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 33751258572     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2006.08.006     Document Type: Article

References (33)

1. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 3 (1992) 65-71
2. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
3. Weidner N., Carroll P.R., Flax J., Blumenfeld W., and Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143 (1993) 401-409
4. Ferrara N., Houck K., Jakeman L., and Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 (1992) 18-32
5. 123I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy. Int J Cancer 91 (2001) 789-796
6. Plate K.H., Breier G., Weich H.A., and Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359 (1992) 845-848
7. Plate K.H., Breier G., Weich H.A., Mennel H.D., and Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59 (1994) 520-529
8. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist 5 Suppl 1 (2000) 3-10
9. Los M., and Voest E.E. The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer. Semin Oncol 28 (2001) 93-105
10. Cross M.J., and Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22 (2001) 201-207
11. Prewett M., Huber J., Li Y., Santiago A., O'Connor W., King K., et al. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res 59 (1999) 5209-5218
12. Gangjee A., Yang J., Ihnat M.A., and Kamat S. Antiangiogenic and antitumor agents: design, synthesis, and evaluation of novel 2-amino-4-(3-bromoanilino)-6-benzylsubstituted pyrrolo[2,3-d]pyrimidines as inhibitors of receptor tyrosine kinases. Bioorg Med Chem 11 (2003) 5155-5170
13. Furet P., Bold G., Hofmann F., Manley P., Meyer T., and Altmann K.H. Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching. Bioorg Med Chem Lett 13 (2003) 2967-2971
14. Ueda Y., Yamagishi T., Samata K., Ikeya H., Hirayama N., Takashima H., et al. A novel low molecular weight antagonist of vascular endothelial growth factor receptor binding: VGA1155. Mol Cancer Ther 2 (2003) 1105-1111
15. 99mTc-MIBI. Microvasc Res 67 (2004) 218-222
16. Cooper M.E., Vranes D., Youssef S., Stacker S.A., Cox A.J., Rizkalla B., et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48 (1999) 2229-2239
17. Asano M., Yukita A., and Suzuki H. Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor. Jpn J Cancer Res 90 (1999) 93-100
18. 124I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography. Cancer Res 62 (2002) 5912-5919
19. 121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem 271 (1996) 5519-5523
20. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., and Heldin C.H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269 (1994) 26988-26995
21. Matthews W., Jordan C.T., Gavin M., Jenkins N.A., Copeland N.G., and Lemischka I.R. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci U S A 88 (1991) 9026-9030
22. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5 (1990) 519-524
23. Peters K.G., De Vries C., and Williams L.T. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A 90 (1993) 8915-8919
24. Millauer B., Wizigmann-Voos S., Schnürch H., Martinez R., Møller N.P., Risau W., et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72 (1993) 835-846
25. Eckelman E.C., and Mathis C.A. Targeting proteins in vivo: in vitro guidelines. Nucl Med Biol 33 (2006) 161-164
26. 165) receptor scintigraphy. Ann Oncol 14 (2003) 1274-1277
27. Takahashi Y., Kitadai Y., Bucana C.D., Cleary K.R., and Ellis L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55 (1995) 3964-3968
28. Laird A.D., Christensen J.G., Li G., Carver J., Smith K., Xin X., et al. SU6668 inhibits Flk-1/KDR and PDGFβ in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice. FASEB J 16 (2002) 681-690
29. 99mTc-EC-endostatin. Cancer Biother Radiopharm 17 (2002) 233-245
30. Lee K.H., Song S.H., Paik J.Y., Byun S.S., Lee S.Y., Choe Y.S., et al. Specific endothelial binding and tumor uptake of radiolabeled angiostatin. Eur J Nucl Med Mol Imaging 30 (2003) 1032-1037
31. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
32. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228
33. Sun B.F., Kobayashi H., Le N., Yoo T.M., Drumm D., Paik C.H., et al. Effects of insulinlike growth factor binding proteins on insulinlike growth factor-I biodistribution in tumor-bearing nude mice. J Nucl Med 41 (2000) 318-326